nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—respiratory system—obesity	0.0268	0.154	CbGeAlD
Lubiprostone—CLCN2—cardiovascular system—obesity	0.0205	0.118	CbGeAlD
Lubiprostone—CLCN2—pituitary gland—obesity	0.0182	0.105	CbGeAlD
Lubiprostone—CLCN2—adrenal gland—obesity	0.0162	0.0934	CbGeAlD
Lubiprostone—CLCN2—endocrine gland—obesity	0.0141	0.081	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—obesity	0.0131	0.0463	CbGpPWpGaD
Lubiprostone—CBR1—islet of Langerhans—obesity	0.0114	0.0655	CbGeAlD
Lubiprostone—CBR1—respiratory system—obesity	0.0107	0.0618	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—GABRA6—obesity	0.0101	0.0356	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—ALOX12—obesity	0.00988	0.0348	CbGpPWpGaD
Lubiprostone—CLCN2—Stimuli-sensing channels—TRPV1—obesity	0.00957	0.0337	CbGpPWpGaD
Lubiprostone—CBR1—adrenal cortex—obesity	0.00901	0.0519	CbGeAlD
Lubiprostone—CBR1—cardiovascular system—obesity	0.00822	0.0473	CbGeAlD
Lubiprostone—CBR1—pituitary gland—obesity	0.00728	0.0419	CbGeAlD
Lubiprostone—CBR1—adipose tissue—obesity	0.00725	0.0418	CbGeAlD
Lubiprostone—CBR1—digestive system—obesity	0.00683	0.0393	CbGeAlD
Lubiprostone—CBR1—adrenal gland—obesity	0.0065	0.0374	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—TRPV1—obesity	0.00624	0.022	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—CES1—obesity	0.00595	0.021	CbGpPWpGaD
Lubiprostone—CBR1—endocrine gland—obesity	0.00564	0.0325	CbGeAlD
Lubiprostone—CBR1—NRF2 pathway—ME1—obesity	0.00553	0.0195	CbGpPWpGaD
Lubiprostone—CBR1—liver—obesity	0.00509	0.0293	CbGeAlD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—obesity	0.00491	0.0173	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—AQP7—obesity	0.00486	0.0172	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—AKR1C3—obesity	0.00474	0.0167	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—FTL—obesity	0.0047	0.0166	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC6A14—obesity	0.00451	0.0159	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC16A7—obesity	0.00445	0.0157	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—LCN2—obesity	0.00414	0.0146	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—COX7C—obesity	0.00389	0.0137	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GGT1—obesity	0.00381	0.0134	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—FTL—obesity	0.00352	0.0124	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GABRA6—obesity	0.00352	0.0124	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—PPARD—obesity	0.00349	0.0123	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC6A14—obesity	0.00337	0.0119	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX1—obesity	0.00301	0.0106	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—G6PD—obesity	0.00283	0.00999	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC9A3—obesity	0.00279	0.00986	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HK2—obesity	0.00266	0.0094	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC27A1—obesity	0.00255	0.00901	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GPX3—obesity	0.0023	0.0081	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPM1L—obesity	0.00219	0.00773	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—INSIG2—obesity	0.00219	0.00773	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TRPV1—obesity	0.00217	0.00766	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HK1—obesity	0.00209	0.00738	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—INPP5E—obesity	0.002	0.00707	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SLC6A4—obesity	0.00192	0.00679	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ME1—obesity	0.00186	0.00657	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC22A1—obesity	0.00185	0.00652	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—obesity	0.00177	0.00625	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PNPLA3—obesity	0.00175	0.00618	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—NQO1—obesity	0.00174	0.00614	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PRKAR2B—obesity	0.0017	0.00601	CbGpPWpGaD
Lubiprostone—Lethargy—Bupropion—obesity	0.00169	0.00313	CcSEcCtD
Lubiprostone—Dinoprostone—SLC22A1—obesity	0.00168	0.573	CrCbGaD
Lubiprostone—Nausea—Benzphetamine—obesity	0.00168	0.00312	CcSEcCtD
Lubiprostone—Gastritis—Sibutramine—obesity	0.00168	0.00311	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Sibutramine—obesity	0.00168	0.0031	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Diethylpropion—obesity	0.00167	0.0031	CcSEcCtD
Lubiprostone—Abdominal pain—Phentermine—obesity	0.00167	0.00309	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—SLC2A4—obesity	0.00167	0.00589	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—DGAT2—obesity	0.00166	0.00586	CbGpPWpGaD
Lubiprostone—Abdominal distension—Sibutramine—obesity	0.00165	0.00306	CcSEcCtD
Lubiprostone—Influenza—Sibutramine—obesity	0.00164	0.00304	CcSEcCtD
Lubiprostone—Dyspnoea—Diethylpropion—obesity	0.00164	0.00303	CcSEcCtD
Lubiprostone—Abdominal discomfort—Orlistat—obesity	0.00163	0.00301	CcSEcCtD
Lubiprostone—Hypersensitivity—Phenylpropanolamine—obesity	0.00163	0.00301	CcSEcCtD
Lubiprostone—Headache—Phendimetrazine—obesity	0.00162	0.003	CcSEcCtD
Lubiprostone—Dyspepsia—Diethylpropion—obesity	0.00162	0.00299	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—GGT1—obesity	0.00162	0.0057	CbGpPWpGaD
Lubiprostone—Gastrooesophageal reflux disease—Topiramate—obesity	0.00161	0.00298	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GCK—obesity	0.0016	0.00566	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Cimetidine—obesity	0.00159	0.00295	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Diethylpropion—obesity	0.00159	0.00294	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LIPE—obesity	0.00158	0.00559	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—MUT—obesity	0.00158	0.00559	CbGpPWpGaD
Lubiprostone—Constipation—Diethylpropion—obesity	0.00157	0.00291	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CETP—obesity	0.00155	0.00546	CbGpPWpGaD
Lubiprostone—Nausea—Phendimetrazine—obesity	0.00153	0.00284	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TF—obesity	0.00153	0.0054	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—DGAT1—obesity	0.00152	0.00536	CbGpPWpGaD
Lubiprostone—Pollakiuria—Sibutramine—obesity	0.00152	0.00281	CcSEcCtD
Lubiprostone—Asthenia—Phentermine—obesity	0.00151	0.00281	CcSEcCtD
Lubiprostone—Feeling abnormal—Diethylpropion—obesity	0.00151	0.0028	CcSEcCtD
Lubiprostone—Fatigue—Cimetidine—obesity	0.00151	0.00279	CcSEcCtD
Lubiprostone—Constipation—Cimetidine—obesity	0.00149	0.00277	CcSEcCtD
Lubiprostone—Weight increased—Sibutramine—obesity	0.00149	0.00277	CcSEcCtD
Lubiprostone—Cramp muscle—Bupropion—obesity	0.00149	0.00276	CcSEcCtD
Lubiprostone—Urinary tract infection—Orlistat—obesity	0.00147	0.00272	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TFRC—obesity	0.00147	0.00518	CbGpPWpGaD
Lubiprostone—Gastritis—Bupropion—obesity	0.00147	0.00271	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACLY—obesity	0.00146	0.00516	CbGpPWpGaD
Lubiprostone—Dizziness—Phenylpropanolamine—obesity	0.00146	0.0027	CcSEcCtD
Lubiprostone—Diarrhoea—Phentermine—obesity	0.00144	0.00268	CcSEcCtD
Lubiprostone—Abdominal distension—Bupropion—obesity	0.00144	0.00267	CcSEcCtD
Lubiprostone—Feeling abnormal—Cimetidine—obesity	0.00144	0.00267	CcSEcCtD
Lubiprostone—Influenza—Bupropion—obesity	0.00143	0.00265	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—HMOX1—obesity	0.00143	0.00505	CbGpPWpGaD
Lubiprostone—Urinary tract infection—Sibutramine—obesity	0.00142	0.00264	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALOX12—obesity	0.00141	0.00498	CbGpPWpGaD
Lubiprostone—Vomiting—Phenylpropanolamine—obesity	0.0014	0.0026	CcSEcCtD
Lubiprostone—Dizziness—Phentermine—obesity	0.0014	0.00259	CcSEcCtD
Lubiprostone—Rash—Phenylpropanolamine—obesity	0.00139	0.00258	CcSEcCtD
Lubiprostone—Dermatitis—Phenylpropanolamine—obesity	0.00139	0.00257	CcSEcCtD
Lubiprostone—Abdominal discomfort—Bupropion—obesity	0.00137	0.00254	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HMGCS1—obesity	0.00137	0.00482	CbGpPWpGaD
Lubiprostone—Vomiting—Phentermine—obesity	0.00134	0.00249	CcSEcCtD
Lubiprostone—Oedema peripheral—Orlistat—obesity	0.00134	0.00248	CcSEcCtD
Lubiprostone—Rash—Phentermine—obesity	0.00133	0.00247	CcSEcCtD
Lubiprostone—Dermatitis—Phentermine—obesity	0.00133	0.00246	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLIN1—obesity	0.00133	0.00468	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ANGPTL4—obesity	0.00133	0.00468	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACADM—obesity	0.00133	0.00468	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PNPLA2—obesity	0.00133	0.00468	CbGpPWpGaD
Lubiprostone—Headache—Phentermine—obesity	0.00132	0.00245	CcSEcCtD
Lubiprostone—Pollakiuria—Bupropion—obesity	0.00132	0.00245	CcSEcCtD
Lubiprostone—Nausea—Phenylpropanolamine—obesity	0.00131	0.00243	CcSEcCtD
Lubiprostone—Weight increased—Bupropion—obesity	0.0013	0.00241	CcSEcCtD
Lubiprostone—Oedema peripheral—Sibutramine—obesity	0.00129	0.0024	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—OXCT1—obesity	0.00129	0.00455	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACACB—obesity	0.00129	0.00455	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Cimetidine—obesity	0.00129	0.00238	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CA3—obesity	0.00129	0.00454	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PNLIP—obesity	0.00126	0.00444	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SRD5A1—obesity	0.00126	0.00444	CbGpPWpGaD
Lubiprostone—Diarrhoea—Diethylpropion—obesity	0.00126	0.00233	CcSEcCtD
Lubiprostone—Nausea—Phentermine—obesity	0.00125	0.00232	CcSEcCtD
Lubiprostone—Asthenia—Cimetidine—obesity	0.00125	0.00232	CcSEcCtD
Lubiprostone—Dinoprostone—CYP19A1—obesity	0.00125	0.426	CrCbGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC2A4—obesity	0.00125	0.0044	CbGpPWpGaD
Lubiprostone—Urinary tract infection—Bupropion—obesity	0.00124	0.0023	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CYCS—obesity	0.00123	0.00434	CbGpPWpGaD
Lubiprostone—Mediastinal disorder—Orlistat—obesity	0.00122	0.00227	CcSEcCtD
Lubiprostone—Dizziness—Diethylpropion—obesity	0.00121	0.00225	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—STS—obesity	0.0012	0.00423	CbGpPWpGaD
Lubiprostone—Diarrhoea—Cimetidine—obesity	0.0012	0.00221	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—NCOA1—obesity	0.00119	0.0042	CbGpPWpGaD
Lubiprostone—Mental disorder—Orlistat—obesity	0.00119	0.0022	CcSEcCtD
Lubiprostone—Malnutrition—Orlistat—obesity	0.00118	0.00219	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARD—obesity	0.00117	0.00414	CbGpPWpGaD
Lubiprostone—Vomiting—Diethylpropion—obesity	0.00117	0.00216	CcSEcCtD
Lubiprostone—Flatulence—Orlistat—obesity	0.00116	0.00216	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLG—obesity	0.00116	0.00409	CbGpPWpGaD
Lubiprostone—Rash—Diethylpropion—obesity	0.00116	0.00214	CcSEcCtD
Lubiprostone—Dysgeusia—Orlistat—obesity	0.00116	0.00214	CcSEcCtD
Lubiprostone—Dermatitis—Diethylpropion—obesity	0.00116	0.00214	CcSEcCtD
Lubiprostone—Dizziness—Cimetidine—obesity	0.00116	0.00214	CcSEcCtD
Lubiprostone—Headache—Diethylpropion—obesity	0.00115	0.00213	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SLC27A1—obesity	0.00115	0.00406	CbGpPWpGaD
Lubiprostone—Malnutrition—Sibutramine—obesity	0.00114	0.00212	CcSEcCtD
Lubiprostone—Muscle spasms—Orlistat—obesity	0.00114	0.0021	CcSEcCtD
Lubiprostone—Oedema peripheral—Bupropion—obesity	0.00113	0.00209	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FABP4—obesity	0.00113	0.00398	CbGpPWpGaD
Lubiprostone—Flatulence—Sibutramine—obesity	0.00113	0.00209	CcSEcCtD
Lubiprostone—Connective tissue disorder—Bupropion—obesity	0.00113	0.00209	CcSEcCtD
Lubiprostone—Dysgeusia—Sibutramine—obesity	0.00112	0.00207	CcSEcCtD
Lubiprostone—Vomiting—Cimetidine—obesity	0.00111	0.00206	CcSEcCtD
Lubiprostone—Rash—Cimetidine—obesity	0.0011	0.00204	CcSEcCtD
Lubiprostone—Dermatitis—Cimetidine—obesity	0.0011	0.00204	CcSEcCtD
Lubiprostone—Muscle spasms—Sibutramine—obesity	0.0011	0.00204	CcSEcCtD
Lubiprostone—Ill-defined disorder—Orlistat—obesity	0.0011	0.00203	CcSEcCtD
Lubiprostone—Headache—Cimetidine—obesity	0.00109	0.00203	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GLRX—obesity	0.00109	0.00386	CbGpPWpGaD
Lubiprostone—Nausea—Diethylpropion—obesity	0.00109	0.00202	CcSEcCtD
Lubiprostone—Lethargy—Topiramate—obesity	0.00108	0.00199	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GNB3—obesity	0.00108	0.00379	CbGpPWpGaD
Lubiprostone—Tremor—Sibutramine—obesity	0.00107	0.00199	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HMOX1—obesity	0.00107	0.00378	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HSD11B1—obesity	0.00107	0.00377	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ECHS1—obesity	0.00107	0.00377	CbGpPWpGaD
Lubiprostone—Malaise—Orlistat—obesity	0.00107	0.00197	CcSEcCtD
Lubiprostone—Ill-defined disorder—Sibutramine—obesity	0.00106	0.00197	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—GNAS—obesity	0.00105	0.00369	CbGpPWpGaD
Lubiprostone—Palpitations—Orlistat—obesity	0.00104	0.00193	CcSEcCtD
Lubiprostone—Nausea—Cimetidine—obesity	0.00104	0.00192	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ACSL1—obesity	0.00104	0.00366	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARGC1B—obesity	0.00104	0.00366	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPAM—obesity	0.00104	0.00366	CbGpPWpGaD
Lubiprostone—Mediastinal disorder—Bupropion—obesity	0.00103	0.00191	CcSEcCtD
Lubiprostone—Malaise—Sibutramine—obesity	0.00103	0.00191	CcSEcCtD
Lubiprostone—Cough—Orlistat—obesity	0.00103	0.00191	CcSEcCtD
Lubiprostone—Syncope—Sibutramine—obesity	0.00103	0.0019	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOB—obesity	0.00103	0.00362	CbGpPWpGaD
Lubiprostone—Palpitations—Sibutramine—obesity	0.00101	0.00187	CcSEcCtD
Lubiprostone—Chest pain—Orlistat—obesity	0.00101	0.00186	CcSEcCtD
Lubiprostone—Myalgia—Orlistat—obesity	0.00101	0.00186	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HADH—obesity	0.00101	0.00355	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FADS1—obesity	0.00101	0.00355	CbGpPWpGaD
Lubiprostone—Loss of consciousness—Sibutramine—obesity	0.00101	0.00186	CcSEcCtD
Lubiprostone—Mental disorder—Bupropion—obesity	0.001	0.00186	CcSEcCtD
Lubiprostone—Anxiety—Orlistat—obesity	0.001	0.00186	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000999	0.00185	CcSEcCtD
Lubiprostone—Cough—Sibutramine—obesity	0.000998	0.00185	CcSEcCtD
Lubiprostone—Malnutrition—Bupropion—obesity	0.000997	0.00185	CcSEcCtD
Lubiprostone—Discomfort—Orlistat—obesity	0.000994	0.00184	CcSEcCtD
Lubiprostone—Dry mouth—Orlistat—obesity	0.000984	0.00182	CcSEcCtD
Lubiprostone—Flatulence—Bupropion—obesity	0.000983	0.00182	CcSEcCtD
Lubiprostone—Dysgeusia—Bupropion—obesity	0.000977	0.00181	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PPM1L—obesity	0.000975	0.00344	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ETFDH—obesity	0.000975	0.00344	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—INSIG2—obesity	0.000975	0.00344	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—OTC—obesity	0.000975	0.00344	CbGpPWpGaD
Lubiprostone—Myalgia—Sibutramine—obesity	0.000974	0.0018	CcSEcCtD
Lubiprostone—Chest pain—Sibutramine—obesity	0.000974	0.0018	CcSEcCtD
Lubiprostone—Anxiety—Sibutramine—obesity	0.000971	0.0018	CcSEcCtD
Lubiprostone—Oedema—Orlistat—obesity	0.000965	0.00179	CcSEcCtD
Lubiprostone—Discomfort—Sibutramine—obesity	0.000962	0.00178	CcSEcCtD
Lubiprostone—Muscle spasms—Bupropion—obesity	0.000959	0.00178	CcSEcCtD
Lubiprostone—Dry mouth—Sibutramine—obesity	0.000953	0.00176	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Topiramate—obesity	0.00095	0.00176	CcSEcCtD
Lubiprostone—Nervous system disorder—Orlistat—obesity	0.000946	0.00175	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SREBF2—obesity	0.000942	0.00332	CbGpPWpGaD
Lubiprostone—Skin disorder—Orlistat—obesity	0.000937	0.00174	CcSEcCtD
Lubiprostone—Tremor—Bupropion—obesity	0.000934	0.00173	CcSEcCtD
Lubiprostone—Gastritis—Topiramate—obesity	0.000934	0.00173	CcSEcCtD
Lubiprostone—Oedema—Sibutramine—obesity	0.000934	0.00173	CcSEcCtD
Lubiprostone—Hyperhidrosis—Orlistat—obesity	0.000933	0.00173	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Topiramate—obesity	0.000931	0.00172	CcSEcCtD
Lubiprostone—Ill-defined disorder—Bupropion—obesity	0.000925	0.00171	CcSEcCtD
Lubiprostone—Shock—Sibutramine—obesity	0.000919	0.0017	CcSEcCtD
Lubiprostone—Abdominal distension—Topiramate—obesity	0.000918	0.0017	CcSEcCtD
Lubiprostone—Tachycardia—Sibutramine—obesity	0.000911	0.00169	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPA—obesity	0.000909	0.00321	CbGpPWpGaD
Lubiprostone—Skin disorder—Sibutramine—obesity	0.000907	0.00168	CcSEcCtD
Lubiprostone—Hyperhidrosis—Sibutramine—obesity	0.000903	0.00167	CcSEcCtD
Lubiprostone—Malaise—Bupropion—obesity	0.000899	0.00167	CcSEcCtD
Lubiprostone—Syncope—Bupropion—obesity	0.000894	0.00166	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GPT—obesity	0.000892	0.00315	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—INPP5E—obesity	0.000892	0.00315	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UQCRC2—obesity	0.000892	0.00315	CbGpPWpGaD
Lubiprostone—Anorexia—Sibutramine—obesity	0.00089	0.00165	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPIN1—obesity	0.00089	0.00314	CbGpPWpGaD
Lubiprostone—Palpitations—Bupropion—obesity	0.000881	0.00163	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Orlistat—obesity	0.000879	0.00163	CcSEcCtD
Lubiprostone—Loss of consciousness—Bupropion—obesity	0.000877	0.00162	CcSEcCtD
Lubiprostone—Abdominal discomfort—Topiramate—obesity	0.000874	0.00162	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA5—obesity	0.000872	0.00308	CbGpPWpGaD
Lubiprostone—Cough—Bupropion—obesity	0.00087	0.00161	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PPARA—obesity	0.000865	0.00305	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Sibutramine—obesity	0.000851	0.00158	CcSEcCtD
Lubiprostone—Dyspepsia—Orlistat—obesity	0.000849	0.00157	CcSEcCtD
Lubiprostone—Chest pain—Bupropion—obesity	0.000849	0.00157	CcSEcCtD
Lubiprostone—Myalgia—Bupropion—obesity	0.000849	0.00157	CcSEcCtD
Lubiprostone—Anxiety—Bupropion—obesity	0.000846	0.00157	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000843	0.00156	CcSEcCtD
Lubiprostone—Pollakiuria—Topiramate—obesity	0.000842	0.00156	CcSEcCtD
Lubiprostone—Discomfort—Bupropion—obesity	0.000839	0.00155	CcSEcCtD
Lubiprostone—Decreased appetite—Orlistat—obesity	0.000839	0.00155	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Orlistat—obesity	0.000833	0.00154	CcSEcCtD
Lubiprostone—Dyspnoea—Sibutramine—obesity	0.000832	0.00154	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CLOCK—obesity	0.000832	0.00293	CbGpPWpGaD
Lubiprostone—Fatigue—Orlistat—obesity	0.000832	0.00154	CcSEcCtD
Lubiprostone—Dry mouth—Bupropion—obesity	0.00083	0.00154	CcSEcCtD
Lubiprostone—Weight increased—Topiramate—obesity	0.00083	0.00154	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SUCLG2—obesity	0.000829	0.00293	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH6A1—obesity	0.000829	0.00293	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ME1—obesity	0.000829	0.00293	CbGpPWpGaD
Lubiprostone—Pain—Orlistat—obesity	0.000825	0.00153	CcSEcCtD
Lubiprostone—Dyspepsia—Sibutramine—obesity	0.000822	0.00152	CcSEcCtD
Lubiprostone—Oedema—Bupropion—obesity	0.000814	0.00151	CcSEcCtD
Lubiprostone—Decreased appetite—Sibutramine—obesity	0.000812	0.0015	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOA1—obesity	0.000811	0.00286	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SULT2A1—obesity	0.000811	0.00286	CbGpPWpGaD
Lubiprostone—Gastrointestinal disorder—Sibutramine—obesity	0.000806	0.00149	CcSEcCtD
Lubiprostone—Shock—Bupropion—obesity	0.000801	0.00148	CcSEcCtD
Lubiprostone—Pain—Sibutramine—obesity	0.000798	0.00148	CcSEcCtD
Lubiprostone—Constipation—Sibutramine—obesity	0.000798	0.00148	CcSEcCtD
Lubiprostone—Nervous system disorder—Bupropion—obesity	0.000798	0.00148	CcSEcCtD
Lubiprostone—Feeling abnormal—Orlistat—obesity	0.000795	0.00147	CcSEcCtD
Lubiprostone—Tachycardia—Bupropion—obesity	0.000794	0.00147	CcSEcCtD
Lubiprostone—Skin disorder—Bupropion—obesity	0.000791	0.00146	CcSEcCtD
Lubiprostone—Urinary tract infection—Topiramate—obesity	0.00079	0.00146	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Orlistat—obesity	0.000789	0.00146	CcSEcCtD
Lubiprostone—Hyperhidrosis—Bupropion—obesity	0.000787	0.00146	CcSEcCtD
Lubiprostone—CBR1—Metabolism—COX7C—obesity	0.00078	0.00275	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PNPLA3—obesity	0.00078	0.00275	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UCP1—obesity	0.00078	0.00275	CbGpPWpGaD
Lubiprostone—Anorexia—Bupropion—obesity	0.000776	0.00144	CcSEcCtD
Lubiprostone—Feeling abnormal—Sibutramine—obesity	0.000769	0.00142	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Sibutramine—obesity	0.000764	0.00141	CcSEcCtD
Lubiprostone—Abdominal pain—Orlistat—obesity	0.000763	0.00141	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Bupropion—obesity	0.000742	0.00137	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CPT1A—obesity	0.000741	0.00262	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DGAT2—obesity	0.000739	0.00261	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CS—obesity	0.000739	0.00261	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CPS1—obesity	0.000739	0.00261	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SUCLA2—obesity	0.000739	0.00261	CbGpPWpGaD
Lubiprostone—Abdominal pain—Sibutramine—obesity	0.000738	0.00137	CcSEcCtD
Lubiprostone—Dyspnoea—Bupropion—obesity	0.000726	0.00134	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LIPC—obesity	0.000722	0.00255	CbGpPWpGaD
Lubiprostone—Oedema peripheral—Topiramate—obesity	0.000719	0.00133	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOC3—obesity	0.000718	0.00253	CbGpPWpGaD
Lubiprostone—Connective tissue disorder—Topiramate—obesity	0.000717	0.00133	CcSEcCtD
Lubiprostone—Dyspepsia—Bupropion—obesity	0.000717	0.00133	CcSEcCtD
Lubiprostone—Hypersensitivity—Orlistat—obesity	0.000711	0.00132	CcSEcCtD
Lubiprostone—Decreased appetite—Bupropion—obesity	0.000708	0.00131	CcSEcCtD
Lubiprostone—CBR1—Metabolism—MUT—obesity	0.000705	0.00249	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LIPE—obesity	0.000705	0.00249	CbGpPWpGaD
Lubiprostone—Gastrointestinal disorder—Bupropion—obesity	0.000703	0.0013	CcSEcCtD
Lubiprostone—Fatigue—Bupropion—obesity	0.000702	0.0013	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CETP—obesity	0.000697	0.00246	CbGpPWpGaD
Lubiprostone—Pain—Bupropion—obesity	0.000696	0.00129	CcSEcCtD
Lubiprostone—Constipation—Bupropion—obesity	0.000696	0.00129	CcSEcCtD
Lubiprostone—Asthenia—Orlistat—obesity	0.000692	0.00128	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SDC1—obesity	0.000689	0.00243	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Sibutramine—obesity	0.000688	0.00127	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AKR1C3—obesity	0.000678	0.00239	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYB5A—obesity	0.000676	0.00239	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DGAT1—obesity	0.000676	0.00239	CbGpPWpGaD
Lubiprostone—Feeling abnormal—Bupropion—obesity	0.000671	0.00124	CcSEcCtD
Lubiprostone—Asthenia—Sibutramine—obesity	0.00067	0.00124	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SCARB1—obesity	0.000668	0.00236	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Bupropion—obesity	0.000666	0.00123	CcSEcCtD
Lubiprostone—Diarrhoea—Orlistat—obesity	0.00066	0.00122	CcSEcCtD
Lubiprostone—Mediastinal disorder—Topiramate—obesity	0.000658	0.00122	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ACLY—obesity	0.000651	0.0023	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SREBF1—obesity	0.000648	0.00229	CbGpPWpGaD
Lubiprostone—Abdominal pain—Bupropion—obesity	0.000643	0.00119	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ALB—obesity	0.000643	0.00227	CbGpPWpGaD
Lubiprostone—Mental disorder—Topiramate—obesity	0.00064	0.00118	CcSEcCtD
Lubiprostone—Diarrhoea—Sibutramine—obesity	0.000639	0.00118	CcSEcCtD
Lubiprostone—Dizziness—Orlistat—obesity	0.000638	0.00118	CcSEcCtD
Lubiprostone—Erythema—Topiramate—obesity	0.000635	0.00118	CcSEcCtD
Lubiprostone—Malnutrition—Topiramate—obesity	0.000635	0.00118	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ENPP1—obesity	0.000629	0.00222	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALOX12—obesity	0.000629	0.00222	CbGpPWpGaD
Lubiprostone—Flatulence—Topiramate—obesity	0.000626	0.00116	CcSEcCtD
Lubiprostone—Dysgeusia—Topiramate—obesity	0.000622	0.00115	CcSEcCtD
Lubiprostone—Dizziness—Sibutramine—obesity	0.000617	0.00114	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FASN—obesity	0.000617	0.00218	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—BCHE—obesity	0.000614	0.00217	CbGpPWpGaD
Lubiprostone—Vomiting—Orlistat—obesity	0.000613	0.00114	CcSEcCtD
Lubiprostone—Muscle spasms—Topiramate—obesity	0.000611	0.00113	CcSEcCtD
Lubiprostone—CBR1—Metabolism—HMGCS1—obesity	0.000609	0.00215	CbGpPWpGaD
Lubiprostone—Rash—Orlistat—obesity	0.000608	0.00113	CcSEcCtD
Lubiprostone—Dermatitis—Orlistat—obesity	0.000608	0.00113	CcSEcCtD
Lubiprostone—Headache—Orlistat—obesity	0.000604	0.00112	CcSEcCtD
Lubiprostone—Hypersensitivity—Bupropion—obesity	0.0006	0.00111	CcSEcCtD
Lubiprostone—Tremor—Topiramate—obesity	0.000595	0.0011	CcSEcCtD
Lubiprostone—Vomiting—Sibutramine—obesity	0.000594	0.0011	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ANGPTL4—obesity	0.000591	0.00209	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACADM—obesity	0.000591	0.00209	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLIN1—obesity	0.000591	0.00209	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SAT1—obesity	0.000591	0.00209	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PNPLA2—obesity	0.000591	0.00209	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PFKFB3—obesity	0.000591	0.00209	CbGpPWpGaD
Lubiprostone—Ill-defined disorder—Topiramate—obesity	0.00059	0.00109	CcSEcCtD
Lubiprostone—Rash—Sibutramine—obesity	0.000589	0.00109	CcSEcCtD
Lubiprostone—Dermatitis—Sibutramine—obesity	0.000588	0.00109	CcSEcCtD
Lubiprostone—Headache—Sibutramine—obesity	0.000585	0.00108	CcSEcCtD
Lubiprostone—Asthenia—Bupropion—obesity	0.000584	0.00108	CcSEcCtD
Lubiprostone—CBR1—Metabolism—OXCT1—obesity	0.000575	0.00203	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYTB—obesity	0.000575	0.00203	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACACB—obesity	0.000575	0.00203	CbGpPWpGaD
Lubiprostone—Nausea—Orlistat—obesity	0.000573	0.00106	CcSEcCtD
Lubiprostone—Malaise—Topiramate—obesity	0.000573	0.00106	CcSEcCtD
Lubiprostone—Syncope—Topiramate—obesity	0.00057	0.00106	CcSEcCtD
Lubiprostone—Palpitations—Topiramate—obesity	0.000562	0.00104	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PNLIP—obesity	0.00056	0.00198	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SRD5A1—obesity	0.00056	0.00198	CbGpPWpGaD
Lubiprostone—Loss of consciousness—Topiramate—obesity	0.000558	0.00103	CcSEcCtD
Lubiprostone—Diarrhoea—Bupropion—obesity	0.000557	0.00103	CcSEcCtD
Lubiprostone—Nausea—Sibutramine—obesity	0.000555	0.00103	CcSEcCtD
Lubiprostone—Cough—Topiramate—obesity	0.000554	0.00103	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SDC3—obesity	0.000547	0.00193	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GGT1—obesity	0.000544	0.00192	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB1—obesity	0.000544	0.00192	CbGpPWpGaD
Lubiprostone—Myalgia—Topiramate—obesity	0.000541	0.001	CcSEcCtD
Lubiprostone—Chest pain—Topiramate—obesity	0.000541	0.001	CcSEcCtD
Lubiprostone—Anxiety—Topiramate—obesity	0.000539	0.000998	CcSEcCtD
Lubiprostone—Dizziness—Bupropion—obesity	0.000538	0.000997	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000537	0.000995	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—NCOA1—obesity	0.000536	0.00189	CbGpPWpGaD
Lubiprostone—Discomfort—Topiramate—obesity	0.000534	0.00099	CcSEcCtD
Lubiprostone—CBR1—Metabolism—STS—obesity	0.000534	0.00189	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP26B1—obesity	0.000534	0.00189	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HK2—obesity	0.000534	0.00189	CbGpPWpGaD
Lubiprostone—Dry mouth—Topiramate—obesity	0.000529	0.00098	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—obesity	0.000528	0.00186	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARD—obesity	0.000523	0.00185	CbGpPWpGaD
Lubiprostone—Oedema—Topiramate—obesity	0.000519	0.00096	CcSEcCtD
Lubiprostone—Vomiting—Bupropion—obesity	0.000518	0.000958	CcSEcCtD
Lubiprostone—Rash—Bupropion—obesity	0.000513	0.000951	CcSEcCtD
Lubiprostone—Dermatitis—Bupropion—obesity	0.000513	0.00095	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SLC27A1—obesity	0.000512	0.00181	CbGpPWpGaD
Lubiprostone—Shock—Topiramate—obesity	0.00051	0.000945	CcSEcCtD
Lubiprostone—Headache—Bupropion—obesity	0.00051	0.000944	CcSEcCtD
Lubiprostone—Nervous system disorder—Topiramate—obesity	0.000509	0.000942	CcSEcCtD
Lubiprostone—Tachycardia—Topiramate—obesity	0.000506	0.000937	CcSEcCtD
Lubiprostone—Skin disorder—Topiramate—obesity	0.000504	0.000933	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GLUL—obesity	0.000502	0.00177	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FABP4—obesity	0.000502	0.00177	CbGpPWpGaD
Lubiprostone—Hyperhidrosis—Topiramate—obesity	0.000501	0.000928	CcSEcCtD
Lubiprostone—Anorexia—Topiramate—obesity	0.000494	0.000915	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	0.000484	0.00171	CbGpPWpGaD
Lubiprostone—Nausea—Bupropion—obesity	0.000483	0.000895	CcSEcCtD
Lubiprostone—CBR1—Metabolism—UCP2—obesity	0.000476	0.00168	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ECHS1—obesity	0.000476	0.00168	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HSD11B1—obesity	0.000476	0.00168	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—UCP3—obesity	0.000476	0.00168	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Topiramate—obesity	0.000472	0.000875	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADH1B—obesity	0.000469	0.00165	CbGpPWpGaD
Lubiprostone—Dyspnoea—Topiramate—obesity	0.000462	0.000856	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOB—obesity	0.000462	0.00163	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARGC1B—obesity	0.000461	0.00163	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPAM—obesity	0.000461	0.00163	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACSL1—obesity	0.000461	0.00163	CbGpPWpGaD
Lubiprostone—Dyspepsia—Topiramate—obesity	0.000456	0.000845	CcSEcCtD
Lubiprostone—Decreased appetite—Topiramate—obesity	0.000451	0.000835	CcSEcCtD
Lubiprostone—CBR1—Metabolism—FADS1—obesity	0.000448	0.00158	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PCK1—obesity	0.000448	0.00158	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HADH—obesity	0.000448	0.00158	CbGpPWpGaD
Lubiprostone—Gastrointestinal disorder—Topiramate—obesity	0.000448	0.000829	CcSEcCtD
Lubiprostone—Fatigue—Topiramate—obesity	0.000447	0.000828	CcSEcCtD
Lubiprostone—Pain—Topiramate—obesity	0.000443	0.000821	CcSEcCtD
Lubiprostone—Constipation—Topiramate—obesity	0.000443	0.000821	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPL—obesity	0.000441	0.00156	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACP5—obesity	0.000436	0.00154	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX1—obesity	0.00043	0.00152	CbGpPWpGaD
Lubiprostone—Feeling abnormal—Topiramate—obesity	0.000427	0.000791	CcSEcCtD
Lubiprostone—CBR1—Metabolism—G6PD—obesity	0.000425	0.0015	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Topiramate—obesity	0.000424	0.000785	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SREBF2—obesity	0.000419	0.00148	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HK1—obesity	0.000419	0.00148	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CD36—obesity	0.000419	0.00148	CbGpPWpGaD
Lubiprostone—Abdominal pain—Topiramate—obesity	0.00041	0.000759	CcSEcCtD
Lubiprostone—CBR1—Metabolism—LPA—obesity	0.000405	0.00143	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LPIN1—obesity	0.000396	0.0014	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARA—obesity	0.000389	0.00137	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA5—obesity	0.000388	0.00137	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Topiramate—obesity	0.000382	0.000708	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AGT—obesity	0.000377	0.00133	CbGpPWpGaD
Lubiprostone—Asthenia—Topiramate—obesity	0.000372	0.000689	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CLOCK—obesity	0.00037	0.00131	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC22A1—obesity	0.00037	0.00131	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOE—obesity	0.00037	0.0013	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CAV1—obesity	0.000366	0.00129	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA1—obesity	0.000365	0.00129	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SULT2A1—obesity	0.000361	0.00127	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GLP1R—obesity	0.000361	0.00127	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DPYD—obesity	0.000355	0.00125	CbGpPWpGaD
Lubiprostone—Diarrhoea—Topiramate—obesity	0.000355	0.000657	CcSEcCtD
Lubiprostone—Dizziness—Topiramate—obesity	0.000343	0.000635	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PRKAR2B—obesity	0.000342	0.00121	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DCN—obesity	0.000339	0.0012	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	0.000334	0.00118	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CPT1A—obesity	0.00033	0.00116	CbGpPWpGaD
Lubiprostone—Vomiting—Topiramate—obesity	0.00033	0.000611	CcSEcCtD
Lubiprostone—Rash—Topiramate—obesity	0.000327	0.000606	CcSEcCtD
Lubiprostone—Dermatitis—Topiramate—obesity	0.000327	0.000605	CcSEcCtD
Lubiprostone—Headache—Topiramate—obesity	0.000325	0.000602	CcSEcCtD
Lubiprostone—CBR1—Metabolism—NAMPT—obesity	0.000324	0.00114	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARG—obesity	0.000322	0.00114	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GCK—obesity	0.000322	0.00114	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LIPC—obesity	0.000322	0.00114	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOC3—obesity	0.00032	0.00113	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—POMC—obesity	0.000317	0.00112	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CETP—obesity	0.00031	0.0011	CbGpPWpGaD
Lubiprostone—Nausea—Topiramate—obesity	0.000308	0.00057	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SDC1—obesity	0.000307	0.00108	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKR1C3—obesity	0.000302	0.00107	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SCARB1—obesity	0.000297	0.00105	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	0.000293	0.00103	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALB—obesity	0.000289	0.00102	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SREBF1—obesity	0.000289	0.00102	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GOT2—obesity	0.000281	0.000991	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	0.000277	0.000977	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FASN—obesity	0.000275	0.000969	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—BCHE—obesity	0.000274	0.000965	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP2E1—obesity	0.000264	0.000931	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NQO1—obesity	0.000261	0.000921	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	0.000256	0.000902	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—obesity	0.000253	0.000893	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GCG—obesity	0.00025	0.000883	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC2A4—obesity	0.00025	0.000883	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYCS—obesity	0.000247	0.000871	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GOT1—obesity	0.000242	0.000855	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GGT1—obesity	0.000242	0.000855	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NCOA1—obesity	0.000239	0.000842	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—STK11—obesity	0.000235	0.00083	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP19A1—obesity	0.000235	0.00083	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—COMT—obesity	0.000219	0.000772	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GNB3—obesity	0.000216	0.000761	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARGC1A—obesity	0.000216	0.000761	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMOX1—obesity	0.000215	0.000757	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GNAS—obesity	0.00021	0.000741	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOB—obesity	0.000206	0.000726	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LPL—obesity	0.000196	0.000693	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX1—obesity	0.000192	0.000676	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CD36—obesity	0.000187	0.000658	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTHFR—obesity	0.000177	0.000624	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARA—obesity	0.000173	0.000612	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AGT—obesity	0.000168	0.000593	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOE—obesity	0.000165	0.000581	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CAV1—obesity	0.000163	0.000575	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA1—obesity	0.000163	0.000574	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	0.000156	0.00055	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CG—obesity	0.000149	0.000524	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARG—obesity	0.000143	0.000506	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—POMC—obesity	0.000141	0.000499	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—INS—obesity	0.000141	0.000496	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CD—obesity	0.000131	0.000461	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALB—obesity	0.000129	0.000455	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3R1—obesity	0.000123	0.000435	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NOS3—obesity	0.000123	0.000435	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CB—obesity	0.000114	0.000402	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—obesity	0.000113	0.000398	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CA—obesity	6.94e-05	0.000245	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKT1—obesity	5.67e-05	0.0002	CbGpPWpGaD
